← Leaderboards
Alavi Abass
University Of Pennsylvania
$273,406
Attributed
$273,406
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$273,406 · 1
By mechanism
M01$273,406 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- David A Mankoff$17,196,499
- Joel S Karp$16,020,052
- Hank F Kung$16,346,808
- Helena Chang Chui$16,982,623
- Suleman Surti$11,398,346
Research focus
Positron Emission TomographyClinical ResearchClinical Trial Phase IComputed Axial TomographyDosageGastrointestinal NeoplasmsHuman SubjectHuman Therapy EvaluationImmunoglobulin GIodineMonoclonal AntibodyCarcinoembryonal AntigenNeoplasm /Cancer RadioimmunotherapyNeoplasm /Cancer Radionuclide TherapyNeoplasm /Cancer Immunotherapy
Grant awards (6)
UPCC 8297: PHASE I RADIOIMMUNOTHERAPY OF GASTROINTESTINAL CANCERS W/ I131$124,146
M01 · FY2002 · RR
UPCC 8297: PHASE I RADIOIMMUNOTHERAPY OF GASTROINTESTINAL CANCERS W/ I131$124,146
M01 · FY2001 · RR
UPCC 8297: PHASE I RADIOIMMUNOTHERAPY OF GASTROINTESTINAL CANCERS W/ I131$0
M01 · FY2001 · RR
UPCC 8297: PHASE I RADIOIMMUNOTHERAPY OF GASTROINTESTINAL CANCERS W/ I131$25,114
M01 · FY2000 · RR
UPCC 8297: PHASE I RADIOIMMUNOTHERAPY OF GASTROINTESTINAL CANCERS W/ I131$0
M01 · FY2000 · RR
UPCC 8297: PHASE I RADIOIMMUNOTHERAPY OF GASTROINTESTINAL CANCERS W/ I131$0
M01 · FY2000 · RR